$Regenxbio (RGNX.US)$ pivotal topline result from CAMPSIIT t...
$Regenxbio(RGNX.US$ pivotal topline result from CAMPSIIT trial are coming. RGX-121 for the treatment a rare genetic disease showing meaningful results. Prior FDA granted Renerative medicine advanced therapy decignition for RGX-121. Let’s see…
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
